Johnson & Johnson

NYSE
JNJ
Stock
Yield per half year: -2.48%
Dividend yield: 3.12%
Sector: Healthcare

Johnson & Johnson

175.00175.00168.00168.00161.00161.00154.00154.00147.00147.00140.00140.00Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
6/10
24.53 52.65 -53.41% 22.42 +9.41%
P/S 3.88 4.03 -3.56%
P/BV 4.83 10.86 -55.57%
P/FCF 22.59 39.64 -43%
Ev/Ebitda 14.43 16.29 -11.43%
Ev/S 4.03 4.35 -7.39%
Ev/FCF 18.02 52.22 -65.49%
E/P 0.0314 0.2095 -85.01%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
8/10
27.9 18.92 47.45% 30.32 -7.99%
ROE 20.06 -83.32 -124.07%
ROA 8.09 6.38 26.86%
ROIC 19.19 15.07 27.38%
ROS 15.84 9.34 69.68%
ROCE 24.4 84.77 -71.22%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
8/10
1.48 1.04 42.39% 1.35 +9.85%
Nеt Debt/Ebitda 0.5056 1.42 -64.36%
Debt/Ratio 0.2034 0.2741 -25.79%
Debt/Equity 1.52 15.68 -90.31%
Debt/Net Income 2.6 6.8 -61.69%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
7.8/10
3.12 1.28 142.81% 3.01 +3.64%
Number of years of dividend growth 40 6.75 492.94%
DSI 1 0.7413 34.89%
Average dividend growth 5.43 -4.1 -232.39%
Average percentage for 5 years 3.01 1.34 125.5%
Average percentage for payments 46.33 44.08 5.09%
Difference from average difference in sector 1.84

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
1/10
7.56 54.39 -86.1%
Growth impulse Ebitda in 5 years 21.83 -89.73 -124.33%
Growth impulse Net Income in 5 years -4.38 -83.26 -94.74%
Growth impulse FCF in 5 years -1.72 -81.95 -97.9%
Growth impulse EPS in 5 years 6.06 39.71 -84.74%
IP Score
6.07/10

Similar companies

AbbVie

Eli Lilly and Company

PFIZER

Zoetis

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription